4//SEC Filing
Downs Christopher 4
Accession 0001683168-21-006141
CIK 0001729427other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:30 AM ET
Size
5.0 KB
Accession
0001683168-21-006141
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-12-06$0.94/sh+5,000$4,702→ 151,500 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.9400 to $0.947299. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001705978
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 8:30 AM ET
- Size
- 5.0 KB